NCI Awards Contracts to Insight Genetics to Develop NSCLC CDx
November 12, 2012
NCI Awards Contracts to Insight Genetics to Develop NSCLC CDx
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Insight Genetics to Participate in NCI's Program to Move Assays to Clinical Trials
April 3, 2013 / GenomeWeb Daily News - Insight Genetics Wins $200K Contract from NCI
November 9, 2010 / GenomeWeb Daily News - Dx Focus: Insight Genetics Chosen for NCI Clinical Assay Development Program
April 4, 2013 / PCR Insider - Qiagen, Eli Lilly Enter CDx Deal
February 14, 2013 / GenomeWeb Daily News - Clarient to Offer Qiagen's Therascreen KRAS Assay as CDx for Erbitux
January 30, 2013 / GenomeWeb Daily News